醫療保健 · 2026 年 9 月 18 日更新 · 閱讀 9 分鐘

中國醫藥企業員工薪酬

This analysis compares A-share companies classified as Pharmaceuticals in the supplied industry dataset. Medical-device and other health-care service companies classified elsewhere are excluded.

分享XLinkedInFacebook

重點摘要

Among 283 A-share pharmaceutical companies, median reported average compensation was CN¥172,683 in 2025, compared with a mean of CN¥199,847.

Companies

283

Pharmaceuticals industry

2025 median

CN¥172,683

Company observations

2025 mean

CN¥199,847

Sensitive to outliers

Business differences among pharmaceutical companies

A research-heavy drug developer and a business with a large manufacturing workforce have different staff mixes. The company table is a starting point for disclosure research, not a ranking adjusted for those business differences.

Top 30 pharmaceutical compensation observations in 2025

Company2025 average compensationYoY changeIndustry
BeOne Medicines Ltd. (688235.SH)CN¥977,254+8.0%醫藥
Dizal Pharmaceutical Co., Ltd. (688192.SH)CN¥667,270-2.8%醫藥
InventisBio Co., Ltd. (688382.SH)CN¥642,582+3.8%醫藥
Jiangsu Yahong Meditech Co., Ltd. (688176.SH)CN¥582,178-7.2%醫藥
Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH)CN¥565,228+2.1%醫藥
Shanghai MicuRx Pharmaceutical Co., Ltd. (688373.SH)CN¥554,498-1.7%醫藥
InnoCare Pharma Limited (688428.SH)CN¥539,564+2.2%醫藥
Shouyao Holdings (Beijing) Co., Ltd. (688197.SH)CN¥463,689+0.0%醫藥
Shanghai Junshi Biosciences Co., Ltd. (688180.SH)CN¥440,100-8.3%醫藥
ACROBIOSYSTEMS CO.,LTD. (301080.SZ)CN¥416,985+12.7%醫藥
Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SH)CN¥407,743-5.1%醫藥
CanSino Biologics Inc. (688185.SH)CN¥390,650+17.6%醫藥
Shenzhen Hepalink Pharmaceutical Group Co.,Ltd. (002399.SZ)CN¥383,097+14.3%醫藥
Hinova Pharmaceuticals Inc. (688302.SH)CN¥364,424-8.9%醫藥
Chongqing Genrix Biopharmaceutical Co., Ltd (688443.SH)CN¥363,676-4.0%醫藥
Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SH)CN¥358,739+11.3%醫藥
Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SH)CN¥358,180+2.6%醫藥
YUNNAN BAIYAO GROUP CO.,LTD (000538.SZ)CN¥353,515+9.2%醫藥
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SH)CN¥350,694+4.2%醫藥
Shanghai OPM Biosciences Co., Ltd. (688293.SH)CN¥346,761+1.0%醫藥
FRONTIER BIOTECHNOLOGIES INC. (688221.SH)CN¥345,121-2.9%醫藥
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (688796.SH)CN¥343,760+16.9%醫藥
HitGen Inc. (688222.SH)CN¥343,220-0.8%醫藥
Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (600276.SH)CN¥343,124+10.9%醫藥
RemeGen Co., Ltd. (688331.SH)CN¥340,660+2.4%醫藥
Betta Pharmaceuticals Co., Ltd. (300558.SZ)CN¥330,884+0.4%醫藥
Beijing Kawin Technology Share-Holding Co., Ltd. (688687.SH)CN¥329,865+5.6%醫藥
Xiamen Amoytop Biotech Co., LTD. (688278.SH)CN¥325,249-1.1%醫藥
BeBetter Med Inc. (688759.SH)CN¥320,610+8.7%醫藥
Changchun High-Tech Industries (Group) Inc. (000661.SZ)CN¥320,523+26.9%醫藥

方法與限制

  • 平均薪酬由公司披露的員工人數及員工薪酬相關數據推算,不代表每名員工的實際薪資。
  • 我們採用中位數降低極端值對行業比較的影響,並同時列出平均數作參考。
  • 缺失值不納入計算;年度比較只包括兩個期間均有數據的公司。
  • 本文僅提供事實性數據分析,不構成投資建議、薦股或資產管理服務。
  • The sample includes companies classified as 医药 (Pharmaceuticals) in the supplied industry dataset.

相關分析